FINHUB Insights

PG · Q4 FY25 · Apr 1 – Jun 30, 2025

Procter & Gamble Q4 FY25: where the revenue came from and where it went

Procter & Gamble Q4 FY25: revenue $20.9B (+2% year over year). Net profit $3.6B. Largest cohort Health Care $12B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Aug 4, 2025 10-K
Sankey diagram of Procter & Gamble's income statement for Q4 FY25: revenue of $20.9 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$20.9B +2% year over year
Gross profit$10.3B 49% margin
Operating profit$4.4B 21% margin
Net profit$3.6B 17% margin

The numbers

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 20.9 100% +2%
Health Care 12 57%
Grooming 6.7 32%
Other 1.4 7%
Corporate 0.8 4%
Cost of revenue−10.651%
Gross profit10.349% margin+0pp
SG&A−5.928%−2pp
Operating profit4.421% margin+2pp
Tax−1
Net profit3.617%+2pp
Filing on EDGAR More quarters of PG

Source of the numbers: tables in the filing (10-K). The diagram is generated automatically and checked against EDGAR before release. The fourth quarter has no column of its own in an annual report, so it is the full year minus the first nine months. How we calculate it → About and methodology.

Older quarters